STEMPOINT CAPITAL LP
Filing Date
Global Rank
#2,587
/ 7,976
▲ 751
Top Industry
Biotechnology
95.9%
3Y Alpha vs SPY
-12.8%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
8 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+17.7%
SPY
+52.9%
Annualised alpha
-12.8%
Max drawdown
−45.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
72 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
12.9%
+5.0 pts
Top 5
35.8%
+1.8 pts
Top 10
54.9%
−0.1 pts
HHI
426
Diversified+11
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.2% | $489,900,413 |
| Unclassified | 0.5% | $2,279,604 |
| Financial Services | 0.3% | $1,590,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | +2,680,406 | 4,197,187 | $63,503,439 | |
| BHVN | Biohaven Ltd. | +1,322,557 | 1,497,311 | $22,474,638 | |
| WVE | Wave Life Sciences Ltd. | +1,209,814 | 2,110,152 | $15,446,312 | |
| DNLI | Denali Therapeutics Inc. | +1,026,744 | 1,734,659 | $25,187,248 | |
| GHRS | GH Research PLC | +444,449 | 545,275 | $7,797,432 | |
| IMVT | Immunovant, Inc. | +438,720 | 1,839,580 | $29,654,029 | |
| RZLT | Rezolute, Inc. | +272,976 | 917,630 | $8,625,722 | |
| SRRK | Scholar Rock Holding Corp | +216,489 | 744,604 | $27,729,052 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +206,221 | 411,893 | $7,764,183 | |
| IDYA | IDEAYA Biosciences, Inc. | +205,940 | 371,825 | $10,117,358 | |
| TECX | Tectonic Therapeutic, Inc. | +148,999 | 188,999 | $2,965,394 | |
| ABVX | Abivax S.A. | +78,525 | 166,273 | $14,116,577 | |
| VTGN | Vistagen Therapeutics, Inc. | +75,431 | 2,488,685 | $8,834,830 | |
| BBIO | BridgeBio Pharma, Inc. | +72,805 | 127,435 | $6,618,973 | |
| TNGX | Tango Therapeutics, Inc. | +36,578 | 245,378 | $2,061,175 | |
| PTGX | Protagonist Therapeutics, Inc | +31,184 | 47,954 | $3,185,584 | |
| SRZN | Surrozen, Inc./DE | +26,924 | 713,463 | $9,192,970 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | −906,429 | 1,466,205 | $22,557,563 | |
| TARA | Protara Therapeutics, Inc. | −780,011 | 363,666 | $1,581,947 | |
| MLYS | Mineralys Therapeutics, Inc. | −473,474 | 158,112 | $5,995,607 | |
| CNTA | Centessa Pharmaceuticals plc | −437,787 | 827,885 | $20,076,211 | |
| TSHA | Taysha Gene Therapies, Inc. | −364,272 | 839,669 | $2,745,717 | |
| KALV | KalVista Pharmaceuticals, Inc. | −330,020 | 56,770 | $691,458 | |
| ACLX | Arcellx, Inc. | −190,076 | 11,376 | $933,969 | |
| ALKS | Alkermes plc. | −109,487 | 241,637 | $7,249,110 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −85,308 | 91,444 | $9,234,929 | |
| MBX | MBX Biosciences, Inc. | −66,021 | 75,000 | $1,312,500 | |
| QURE | uniQure N.V. | −50,460 | 522,155 | $30,478,187 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | −44,487 | 8,207 | $3,764,222 | |
| ORIC | Oric Pharmaceuticals, Inc. | −34,324 | 166,461 | $1,997,532 | |
| INSM | INSMED Inc | −18,159 | 43,419 | $6,252,770 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −2,079 | 150,573 | $4,282,296 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ARGX | Argenx SE | 12,465 | $9,193,685 | |
| RVMD | Revolution Medicines, Inc. | 185,380 | $8,657,246 | |
| XENE | Xenon Pharmaceuticals Inc. | 192,295 | $7,720,644 | |
| CELC | Celcuity Inc. | 136,710 | $6,753,474 | |
| DYN | Dyne Therapeutics, Inc. | 474,612 | $6,003,841 | |
| JAZZ | Jazz Pharmaceuticals plc | 39,072 | $5,149,689 | |
| OCUL | Ocular Therapeutix, Inc | 359,470 | $4,202,204 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 276,884 | $3,762,853 | |
| INCY | Incyte Corp | 43,754 | $3,710,776 | |
| GPCR | Structure Therapeutics Inc. | 129,335 | $3,621,380 | |
| IONS | Ionis Pharmaceuticals Inc | 50,000 | $3,271,000 | |
| TRVI | Trevi Therapeutics, Inc. | 350,710 | $3,208,996 | |
| NKTR | Nektar Therapeutics | 53,201 | $3,027,136 | |
| ASND | Ascendis Pharma A/S | 15,149 | $3,011,772 | |
| HROW | Harrow, Inc. | 57,619 | $2,776,083 | |
| EQ | Equillium, Inc. | 1,908,935 | $2,729,777 | |
| UTHR | UNITED THERAPEUTICS Corp | 6,264 | $2,625,931 | |
| CRSP | CRISPR Therapeutics AG | 40,000 | $2,592,400 | |
| CGON | CG Oncology, Inc. | 63,019 | $2,538,405 | |
| QQQ | Invesco Qqq Trust, Series 1 | 3,797 | $2,279,604 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 186,614 | $2,160,990 | |
| XFOR | X4 Pharmaceuticals, Inc | 555,411 | $1,899,505 | |
| PEPG | PepGen Inc. | 389,189 | $1,798,053 | |
| ASMB | Assembly Biosciences, Inc. | 66,130 | $1,692,928 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 41,382 | $1,628,381 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GERN | Geron Corp | 6,949,244 | $9,798,434 | |
| LEGN | Legend Biotech Corp | 270,144 | $9,587,410 | |
| ZLAB | Zai Lab Ltd | 250,438 | $8,757,816 | |
| LENZ | LENZ Therapeutics, Inc. | 183,912 | $5,390,460 | |
| NUVL | Nuvalent, Inc. | 59,828 | $4,564,876 | |
| APGE | Apogee Therapeutics, Inc. | 84,466 | $3,668,358 | |
| EYPT | EyePoint, Inc. | 329,254 | $3,098,280 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 4,672 | $2,452,800 | |
| JANX | Janux Therapeutics, Inc. | 89,933 | $2,077,452 | |
| PRAX | Praxis Precision Medicines, Inc. | 32,255 | $1,356,322 | |
| No positions match the current search. | ||||
72 positions ·
$493,770,017 total
· as of Sep 30, 2025
Showing 1–50
of 72 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 4,197,187 | $63,503,439 | 12.86% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 522,155 | $30,478,187 | 6.17% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 1,839,580 | $29,654,029 | 6.01% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 744,604 | $27,729,052 | 5.62% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 1,734,659 | $25,187,248 | 5.10% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 1,466,205 | $22,557,563 | 4.57% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Added | 1,497,311 | $22,474,638 | 4.55% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 827,885 | $20,076,211 | 4.07% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Added | 2,110,152 | $15,446,312 | 3.13% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 166,273 | $14,116,577 | 2.86% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 371,825 | $10,117,358 | 2.05% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 91,444 | $9,234,929 | 1.87% | |
| ARGX |
Argenx SE
Healthcare
|
NEW | 12,465 | $9,193,685 | 1.86% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 713,463 | $9,192,970 | 1.86% | |
| VTGN |
Vistagen Therapeutics, Inc.
Healthcare
|
Added | 2,488,685 | $8,834,830 | 1.79% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
NEW | 185,380 | $8,657,246 | 1.75% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Added | 917,630 | $8,625,722 | 1.75% | |
| GHRS |
GH Research PLC
Healthcare
|
Added | 545,275 | $7,797,432 | 1.58% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 411,893 | $7,764,183 | 1.57% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 192,295 | $7,720,644 | 1.56% | |
| ALKS |
Alkermes plc.
Healthcare
|
Reduced | 241,637 | $7,249,110 | 1.47% | |
| CELC |
Celcuity Inc.
Healthcare
|
NEW | 136,710 | $6,753,474 | 1.37% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 127,435 | $6,618,973 | 1.34% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 43,419 | $6,252,770 | 1.27% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
NEW | 474,612 | $6,003,841 | 1.22% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 158,112 | $5,995,607 | 1.21% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
NEW | 39,072 | $5,149,689 | 1.04% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 150,573 | $4,282,296 | 0.87% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
NEW | 359,470 | $4,202,204 | 0.85% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Reduced | 8,207 | $3,764,222 | 0.76% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
NEW | 276,884 | $3,762,853 | 0.76% | |
| INCY |
Incyte Corp
Healthcare
|
NEW | 43,754 | $3,710,776 | 0.75% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 129,335 | $3,621,380 | 0.73% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
NEW | 50,000 | $3,271,000 | 0.66% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
NEW | 350,710 | $3,208,996 | 0.65% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 47,954 | $3,185,584 | 0.65% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
NEW | 53,201 | $3,027,136 | 0.61% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
NEW | 15,149 | $3,011,772 | 0.61% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Added | 188,999 | $2,965,394 | 0.60% | |
| HROW |
Harrow, Inc.
Healthcare
|
NEW | 57,619 | $2,776,083 | 0.56% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Reduced | 839,669 | $2,745,717 | 0.56% | |
| EQ |
Equillium, Inc.
Healthcare
|
NEW | 1,908,935 | $2,729,777 | 0.55% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
NEW | 6,264 | $2,625,931 | 0.53% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
NEW | 40,000 | $2,592,400 | 0.53% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
NEW | 63,019 | $2,538,405 | 0.51% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
NEW | 3,797 | $2,279,604 | 0.46% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
NEW | 186,614 | $2,160,990 | 0.44% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 245,378 | $2,061,175 | 0.42% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 166,461 | $1,997,532 | 0.40% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
NEW | 555,411 | $1,899,505 | 0.38% |